Personalis Inc. (PSNL) NASDAQ
$1.43 (0.09) (-5.92%)
Market Cap: $74.27M
As of 05/15/24 04:00 PM EDT. Market closed.
Personalis Inc. (PSNL)
NASDAQ
$1.43
(0.09) (-5.92%)
Market Cap: $74.27M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
John West
Full Time Employees
428
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
John West
Full Time Employees
428
Address
1330 Obrien Dr, California, Menlo Park, 94025-1436.
PRICE CHART FOR PERSONALIS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.45
Previous Close
$1.52
Days Range
$1.43 - $1.56
52 week range
$0.89 - $2.60
Volume
225,346
Avg. Volume (30 days)
240,177
Market Cap
$74.27M
Dividend Yield
-
P/E
(0.80)
Shares Outstanding
51,938,839
Open
$1.45
Previous Close
$1.52
Days Range
$1.43 - $1.56
52 week range
$0.89 - $2.60
Volume
225,346
Avg. Volume (30 days)
240,177
Market Cap
$74.27M
Dividend Yield
-
P/E
(0.80)
Shares Outstanding
51,938,839
FINANCIAL STATEMENTS FOR PERSONALIS INC
LOADING...
INSIDER TRANSACTIONS FOR PERSONALIS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Moore Stephen Michael | SVP and Chief Legal Officer | Apr 30, 2024 | Sale | $1.37 | 4,523 | 6,197 | 72,397 | May 02, 2024, 05:52 PM |
MYERS WOODROW A JR | Director | Mar 01, 2024 | Buy | $1.67 | 10,000 | 16,700 | 26,116 | Mar 05, 2024, 05:15 PM |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP | Jan 29, 2024 | Sale | $1.37 | 526 | 721 | 128,870 | Jan 31, 2024, 04:30 PM |
Tachibana Aaron | CFO AND COO | Jan 29, 2024 | Sale | $1.37 | 716 | 981 | 184,521 | Jan 31, 2024, 04:27 PM |
Chen Richard | Chief Medical Officer and EVP | Dec 15, 2023 | Sale | $1.47 | 4,708 | 6,921 | 129,396 | Dec 19, 2023, 06:09 PM |
Tachibana Aaron | CFO and COO | Dec 15, 2023 | Sale | $1.47 | 6,747 | 9,918 | 185,237 | Dec 19, 2023, 06:07 PM |
Moore Stephen Michael | General Counsel | Dec 15, 2023 | Sale | $1.47 | 1,476 | 2,170 | 76,920 | Dec 19, 2023, 06:02 PM |
Moore Stephen Michael | General Counsel | Nov 16, 2023 | Sale | $1.04 | 1,722 | 1,791 | 78,396 | Nov 20, 2023, 04:30 PM |
Tachibana Aaron | CFO and COO | Nov 16, 2023 | Sale | $1.04 | 1,344 | 1,398 | 191,984 | Nov 20, 2023, 04:30 PM |
Chen Richard | Chief Medical Officer and EVP | Nov 16, 2023 | Sale | $1.04 | 940 | 978 | 124,104 | Nov 20, 2023, 04:30 PM |
Hall Christopher M | President and CEO | Nov 01, 2023 | Sale | $0.93 | 20,459 | 19,027 | 204,541 | Nov 03, 2023, 09:00 PM |
Tachibana Aaron | CFO and COO | Jul 31, 2023 | Sale | $2.26 | 662 | 1,496 | 193,328 | Aug 02, 2023, 04:21 PM |
Chen Richard | Chief Medical Officer and EVP | Jul 31, 2023 | Sale | $2.26 | 485 | 1,096 | 125,044 | Aug 02, 2023, 04:20 PM |
Moore Stephen Michael | General Counsel | Jun 16, 2023 | Sale | $2.07 | 1,509 | 3,124 | 80,118 | Jun 21, 2023, 04:52 PM |
Chen Richard | Chief Medical Officer and EVP | Jun 16, 2023 | Sale | $2.07 | 4,817 | 9,971 | 125,529 | Jun 21, 2023, 04:51 PM |
Tachibana Aaron | CFO and COO | Jun 16, 2023 | Sale | $2.07 | 6,904 | 14,291 | 193,990 | Jun 21, 2023, 04:49 PM |
Tachibana Aaron | CFO and COO | May 17, 2023 | Sale | $1.98 | 1,389 | 2,750 | 200,894 | May 19, 2023, 05:42 PM |
Moore Stephen Michael | General Counsel | May 17, 2023 | Sale | $1.98 | 1,781 | 3,526 | 81,627 | May 19, 2023, 05:39 PM |
Chen Richard | Chief Medical Officer and EVP | May 17, 2023 | Sale | $1.98 | 971 | 1,923 | 130,346 | May 19, 2023, 05:37 PM |
Moore Stephen Michael | General Counsel | May 02, 2023 | Sale | $2.29 | 5,102 | 11,684 | 83,408 | May 04, 2023, 04:17 PM |
Tachibana Aaron | CFO and COO | Mar 17, 2023 | Sale | $2.83 | 3,945 | 11,164 | 202,283 | Mar 21, 2023, 06:00 PM |
Chen Richard | Chief Medical Officer and EVP | Mar 17, 2023 | Sale | $2.83 | 1,314 | 3,719 | 131,317 | Mar 21, 2023, 05:57 PM |
Tachibana Aaron | Chief Financial Officer | Jan 31, 2023 | Sale | $2.20 | 767 | 1,687 | 206,228 | Feb 02, 2023, 05:12 PM |
Chen Richard | Chief Medical Officer | Jan 31, 2023 | Sale | $2.20 | 562 | 1,236 | 132,631 | Feb 02, 2023, 05:09 PM |
Tachibana Aaron | Chief Financial Officer | Dec 20, 2022 | Sale | $1.92 | 3,843 | 7,379 | 206,995 | Dec 22, 2022, 05:07 PM |
Chen Richard | Chief Medical Officer | Dec 20, 2022 | Sale | $1.92 | 1,750 | 3,360 | 133,193 | Dec 22, 2022, 05:03 PM |
Moore Stephen Michael | General Counsel | Dec 15, 2022 | Sale | $2.50 | 1,930 | 4,825 | 88,510 | Dec 19, 2022, 04:32 PM |
Tachibana Aaron | Chief Financial Officer | Dec 15, 2022 | Sale | $2.50 | 7,177 | 17,943 | 210,838 | Dec 19, 2022, 04:28 PM |
Chen Richard | Chief Medical Officer | Dec 15, 2022 | Sale | $2.50 | 7,177 | 17,943 | 134,943 | Dec 19, 2022, 04:23 PM |
West John Stephen | President and CEO | Dec 14, 2022 | Option Exercise | $2.44 | 10,000 | 24,400 | 622,444 | Dec 14, 2022, 04:03 PM |
Tachibana Aaron | Chief Financial Officer | Dec 02, 2022 | Sale | $2.60 | 4,360 | 11,336 | 218,015 | Dec 06, 2022, 04:54 PM |
Chen Richard | Chief Medical Officer | Dec 02, 2022 | Sale | $2.60 | 440 | 1,144 | 142,120 | Dec 06, 2022, 04:50 PM |
Chen Richard | Chief Medical Officer | Nov 16, 2022 | Sale | $2.71 | 1,295 | 3,509 | 142,560 | Nov 18, 2022, 05:02 PM |
Moore Stephen Michael | General Counsel | Nov 16, 2022 | Sale | $2.71 | 2,045 | 5,542 | 90,440 | Nov 18, 2022, 04:48 PM |
Tachibana Aaron | Chief Financial Officer | Nov 16, 2022 | Sale | $2.71 | 1,294 | 3,507 | 222,375 | Nov 18, 2022, 04:43 PM |
Chen Richard | Chief Medical Officer | Sep 20, 2022 | Sale | $3.48 | 1,581 | 5,502 | 143,855 | Sep 22, 2022, 04:13 PM |
Tachibana Aaron | Chief Financial Officer | Sep 20, 2022 | Sale | $3.48 | 3,474 | 12,090 | 223,669 | Sep 22, 2022, 04:09 PM |
Chen Richard | Chief Medical Officer | Sep 02, 2022 | Sale | $3.33 | 420 | 1,399 | 145,436 | Sep 08, 2022, 04:18 PM |
Tachibana Aaron | Chief Financial Officer | Sep 02, 2022 | Sale | $3.33 | 4,168 | 13,879 | 227,143 | Sep 08, 2022, 04:09 PM |
Chen Richard | Chief Medical Officer | Jul 28, 2022 | Sale | $3.91 | 632 | 2,471 | 145,856 | Aug 01, 2022, 06:12 PM |
Tachibana Aaron | Chief Financial Officer | Jul 28, 2022 | Sale | $3.91 | 632 | 2,471 | 231,311 | Aug 01, 2022, 06:05 PM |
Chen Richard | Chief Medical Officer | Jun 17, 2022 | Sale | $3.29 | 1,565 | 5,149 | 146,488 | Jun 21, 2022, 04:52 PM |
Tachibana Aaron | Chief Financial Officer | Jun 17, 2022 | Sale | $3.29 | 3,440 | 11,318 | 231,943 | Jun 21, 2022, 04:48 PM |
Moore Stephen Michael | General Counsel | Jun 15, 2022 | Sale | $3.24 | 1,832 | 5,936 | 73,885 | Jun 17, 2022, 05:11 PM |
Chen Richard | Chief Medical Officer | Jun 15, 2022 | Sale | $3.24 | 6,818 | 22,090 | 148,053 | Jun 17, 2022, 05:08 PM |
Tachibana Aaron | Chief Financial Officer | Jun 15, 2022 | Sale | $3.24 | 6,818 | 22,090 | 235,383 | Jun 17, 2022, 05:02 PM |
Tachibana Aaron | Chief Financial Officer | Jun 02, 2022 | Sale | $3.59 | 4,187 | 15,031 | 242,201 | Jun 06, 2022, 05:36 PM |
Chen Richard | Chief Medical Officer | Jun 02, 2022 | Sale | $3.59 | 421 | 1,511 | 154,871 | Jun 06, 2022, 05:30 PM |
Tachibana Aaron | Chief Financial Officer | May 16, 2022 | Sale | $4.86 | 1,286 | 6,250 | 246,388 | May 18, 2022, 06:17 PM |
West John Stephen | President and CEO | May 16, 2022 | Sale | $4.86 | 2,408 | 11,703 | 382,444 | May 18, 2022, 06:16 PM |
Moore Stephen Michael | General Counsel | May 16, 2022 | Sale | $4.86 | 664 | 3,227 | 75,717 | May 18, 2022, 06:15 PM |
Chen Richard | Chief Medical Officer | Apr 29, 2022 | Option Exercise | $4.76 | 1,558 | 7,416 | 157,116 | May 18, 2022, 06:14 PM |
Chen Richard | Chief Medical Officer | May 16, 2022 | Sale | $4.86 | 1,286 | 6,250 | 155,830 | May 18, 2022, 06:14 PM |
Moore Stephen Michael | General Counsel | May 02, 2022 | Sale | $5.53 | 5,733 | 31,703 | 76,381 | May 04, 2022, 05:38 PM |
West John Stephen | President and CEO | Apr 20, 2022 | Option Exercise | $1.84 | 45,061 | 82,912 | 384,852 | Apr 22, 2022, 05:25 PM |
West John Stephen | President and CEO | Apr 13, 2022 | Option Exercise | $1.84 | 64,430 | 118,551 | 404,221 | Apr 15, 2022, 06:24 PM |
West John Stephen | President and CEO | Mar 17, 2022 | Option Exercise | $1.84 | 54,347 | 99,998 | 339,804 | Mar 21, 2022, 08:44 PM |
Tachibana Aaron | Chief Financial Officer | Mar 17, 2022 | Option Exercise | $7.98 | 3,767 | 30,061 | 247,674 | Mar 21, 2022, 08:42 PM |
Chen Richard | Chief Medical Officer | Mar 17, 2022 | Option Exercise | $7.98 | 1,776 | 14,172 | 155,558 | Mar 21, 2022, 08:41 PM |
West John Stephen | President and CEO | Mar 15, 2022 | Option Exercise | $1.84 | 68,162 | 125,418 | 353,619 | Mar 16, 2022, 08:40 PM |
West John Stephen | President and CEO | Mar 14, 2022 | Option Exercise | $1.84 | 21,206 | 39,019 | 306,663 | Mar 16, 2022, 08:40 PM |
West John Stephen | President and CEO | Mar 15, 2022 | Option Exercise | $7.47 | 68,162 | 509,170 | 285,457 | Mar 16, 2022, 08:40 PM |
West John Stephen | President and CEO | Mar 14, 2022 | Option Exercise | $8.15 | 21,206 | 172,829 | 285,457 | Mar 16, 2022, 08:40 PM |
West John Stephen | President and CEO | Mar 11, 2022 | Option Exercise | $1.84 | 10,888 | 20,034 | 296,339 | Mar 16, 2022, 08:39 PM |
West John Stephen | President and CEO | Mar 10, 2022 | Option Exercise | $1.84 | 32,897 | 60,530 | 318,354 | Mar 16, 2022, 08:39 PM |
West John Stephen | President and CEO | Mar 11, 2022 | Option Exercise | $8.99 | 10,888 | 97,883 | 285,457 | Mar 16, 2022, 08:39 PM |
West John Stephen | President and CEO | Mar 10, 2022 | Option Exercise | $9.38 | 32,897 | 308,574 | 285,457 | Mar 16, 2022, 08:39 PM |
West John Stephen | President and CEO | Mar 11, 2022 | Option Exercise | $8.99 | 10,888 | 97,883 | 241,672 | Mar 14, 2022, 05:56 PM |
West John Stephen | President and CEO | Mar 10, 2022 | Option Exercise | $9.38 | 32,897 | 308,574 | 252,560 | Mar 14, 2022, 05:56 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Mar 03, 2022 | Buy | $10.38 | 4,750 | 49,305 | 4,750 | Mar 04, 2022, 08:27 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Mar 03, 2022 | Buy | $9.83 | 261,011 | 2,565,738 | 2,084,240 | Mar 04, 2022, 08:27 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Mar 02, 2022 | Buy | $9.96 | 48,989 | 487,930 | 1,823,229 | Mar 04, 2022, 08:27 PM |
Chen Richard | Chief Medical Officer | Mar 02, 2022 | Sale | $10.18 | 471 | 4,795 | 157,334 | Mar 04, 2022, 06:09 PM |
Tachibana Aaron | Chief Financial Officer | Mar 02, 2022 | Sale | $10.18 | 4,511 | 45,922 | 251,441 | Mar 04, 2022, 06:08 PM |
Chen Richard | Chief Medical Officer | Jan 28, 2022 | Sale | $9.93 | 705 | 7,001 | 157,805 | Feb 01, 2022, 06:05 PM |
Tachibana Aaron | Chief Financial Officer | Jan 28, 2022 | Sale | $9.93 | 705 | 7,001 | 255,952 | Feb 01, 2022, 06:04 PM |
West John Stephen | President and CEO | Jan 19, 2022 | Sale | $11.01 | 64,503 | 710,178 | 285,457 | Jan 19, 2022, 07:22 PM |
West John Stephen | President and CEO | Jan 18, 2022 | Sale | $11.73 | 35,484 | 416,227 | 349,960 | Jan 19, 2022, 07:22 PM |
Tachibana Aaron | Chief Financial Officer | Dec 17, 2021 | Sale | $12.80 | 3,437 | 43,994 | 256,657 | Dec 20, 2021, 07:59 PM |
Chen Richard | Chief Medical Officer | Dec 17, 2021 | Sale | $12.80 | 1,563 | 20,006 | 158,510 | Dec 20, 2021, 07:10 PM |
West John Stephen | President and CEO | Dec 17, 2021 | Sale | $12.80 | 2,732 | 34,970 | 385,444 | Dec 20, 2021, 07:00 PM |
West John Stephen | President and CEO | Dec 16, 2021 | Sale | $13.42 | 97,268 | 1,305,337 | 388,176 | Dec 17, 2021, 09:17 PM |
Chen Richard | Chief Medical Officer | Dec 02, 2021 | Sale | $12.92 | 419 | 5,413 | 80,073 | Dec 06, 2021, 06:06 PM |
Tachibana Aaron | Chief Financial Officer | Dec 02, 2021 | Sale | $12.92 | 4,184 | 54,057 | 180,094 | Dec 06, 2021, 06:05 PM |
West John Stephen | President and CEO | Nov 30, 2021 | Sale | $13.65 | 100,000 | 1,365,000 | 485,444 | Dec 02, 2021, 05:49 PM |
West John Stephen | President and CEO | Nov 17, 2021 | Sale | $17.04 | 2,348 | 40,010 | 585,444 | Nov 19, 2021, 06:15 PM |
Tachibana Aaron | Chief Financial Officer | Nov 17, 2021 | Sale | $17.04 | 1,253 | 21,351 | 184,278 | Nov 19, 2021, 06:14 PM |
Chen Richard | Chief Medical Officer | Oct 29, 2021 | Option Exercise | $16.68 | 711 | 11,859 | 80,492 | Nov 19, 2021, 06:12 PM |
Chen Richard | Chief Medical Officer | Nov 17, 2021 | Sale | $17.04 | 1,253 | 21,351 | 79,781 | Nov 19, 2021, 06:12 PM |
West John Stephen | President and CEO | Oct 12, 2021 | Sale | $19.33 | 100,000 | 1,933,000 | 587,792 | Oct 14, 2021, 06:24 PM |
Tachibana Aaron | Chief Financial Officer | Sep 17, 2021 | Sale | $21.25 | 3,152 | 66,980 | 185,531 | Sep 21, 2021, 06:36 PM |
Chen Richard | Chief Scientific Officer | Sep 17, 2021 | Sale | $21.25 | 1,088 | 23,120 | 81,034 | Sep 21, 2021, 06:35 PM |
West John Stephen | President and CEO | Sep 14, 2021 | Option Exercise | $21.69 | 100,000 | 2,169,158 | 694,392 | Sep 16, 2021, 06:28 PM |
Tachibana Aaron | Chief Financial Officer | Sep 02, 2021 | Sale | $21.92 | 3,820 | 83,734 | 188,683 | Sep 07, 2021, 05:51 PM |
Chen Richard | Chief Scientific Officer | Sep 02, 2021 | Sale | $21.92 | 291 | 6,379 | 82,122 | Sep 07, 2021, 05:50 PM |
West John Stephen | President and CEO | Aug 26, 2021 | Option Exercise | $0.44 | 77,272 | 34,000 | 787,792 | Aug 30, 2021, 05:52 PM |
West John Stephen | President and CEO | Aug 19, 2021 | Option Exercise | $0.44 | 115,228 | 50,700 | 825,748 | Aug 23, 2021, 06:14 PM |
West John Stephen | President and CEO | Aug 19, 2021 | Option Exercise | $16.81 | 115,228 | 1,936,983 | 710,520 | Aug 23, 2021, 06:14 PM |
Chen Richard | Chief Scientific Officer | Aug 06, 2021 | Option Exercise | $21.18 | 15,564 | 329,646 | 86,849 | Aug 10, 2021, 05:19 PM |
Chen Richard | Chief Scientific Officer | Aug 06, 2021 | Sale | $21.22 | 4,436 | 94,132 | 82,413 | Aug 10, 2021, 05:19 PM |
West John Stephen | President and CEO | Jul 15, 2021 | Option Exercise | $0.44 | 75,000 | 33,000 | 710,520 | Jul 20, 2021, 06:34 PM |
West John Stephen | President and CEO | Jul 08, 2021 | Option Exercise | $0.44 | 110,000 | 48,400 | 745,520 | Jul 12, 2021, 05:07 PM |
West John Stephen | President and CEO | Jul 08, 2021 | Sale | $22.54 | 110,000 | 2,479,400 | 635,520 | Jul 12, 2021, 05:07 PM |
West John Stephen | President and CEO | Jun 08, 2021 | Option Exercise | $0.44 | 110,000 | 48,400 | 670,520 | Jun 10, 2021, 05:17 PM |
West John Stephen | President and CEO | Jun 08, 2021 | Sale | $22.43 | 110,000 | 2,467,272 | 570,470 | Jun 10, 2021, 05:17 PM |
Chen Richard | Chief Scientific Officer | Jun 02, 2021 | Sale | $21.57 | 291 | 6,277 | 76,081 | Jun 04, 2021, 06:46 PM |
Chen Richard | Chief Scientific Officer | Mar 17, 2021 | Sale | $26.73 | 1,130 | 30,205 | 83,317 | Mar 19, 2021, 05:48 PM |
Tachibana Aaron | Chief Financial Officer | Mar 17, 2021 | Sale | $26.73 | 2,446 | 65,382 | 167,823 | Mar 19, 2021, 05:47 PM |
Tachibana Aaron | Chief Financial Officer | Mar 02, 2021 | Sale | $32.60 | 3,022 | 98,517 | 170,269 | Mar 04, 2021, 07:22 PM |
Chen Richard | Chief Scientific Officer | Mar 02, 2021 | Sale | $32.60 | 345 | 11,247 | 84,447 | Mar 04, 2021, 07:21 PM |
Chen Richard | Chief Scientific Officer | Feb 01, 2021 | Option Exercise | $0.44 | 13,422 | 5,906 | 98,214 | Feb 03, 2021, 06:24 PM |
Chen Richard | Chief Scientific Officer | Feb 01, 2021 | Sale | $38.67 | 40,000 | 1,546,993 | 104,851 | Feb 03, 2021, 06:24 PM |
Chen Richard | Chief Scientific Officer | Dec 17, 2020 | Sale | $36.37 | 1,087 | 39,534 | 111,370 | Dec 21, 2020, 06:18 PM |
Tachibana Aaron | Chief Financial Officer | Dec 17, 2020 | Sale | $36.37 | 2,391 | 86,961 | 173,291 | Dec 21, 2020, 06:18 PM |
Chen Richard | Chief Scientific Officer | Dec 01, 2020 | Option Exercise | $0.44 | 40,000 | 17,600 | 152,750 | Dec 03, 2020, 07:23 PM |
Chen Richard | Chief Scientific Officer | Dec 01, 2020 | Sale | $28.00 | 40,000 | 1,119,989 | 138,362 | Dec 03, 2020, 07:23 PM |
Chen Richard | Chief Scientific Officer | Dec 02, 2020 | Sale | $27.76 | 293 | 8,134 | 112,457 | Dec 03, 2020, 07:23 PM |
Tachibana Aaron | Chief Financial Officer | Dec 02, 2020 | Sale | $27.76 | 2,926 | 81,226 | 175,682 | Dec 03, 2020, 07:21 PM |
Abingworth LLP | Former 10% Owner | Oct 20, 2020 | Sale | $27.66 | 130,486 | 3,609,243 | 3,753,340 | Oct 21, 2020, 04:05 PM |
Abingworth LLP | 10% Owner | Oct 19, 2020 | Sale | $27.86 | 196,423 | 5,472,345 | 3,883,826 | Oct 20, 2020, 04:06 PM |
Abingworth LLP | 10% Owner | Oct 16, 2020 | Sale | $26.68 | 94,218 | 2,513,736 | 4,080,249 | Oct 20, 2020, 04:06 PM |
Abingworth LLP | 10% Owner | Oct 15, 2020 | Sale | $26.32 | 3,700 | 97,384 | 4,174,467 | Oct 16, 2020, 04:05 PM |
Abingworth LLP | 10% Owner | Oct 14, 2020 | Sale | $27.08 | 81,925 | 2,218,529 | 4,178,167 | Oct 16, 2020, 04:05 PM |
Abingworth LLP | 10% Owner | Oct 13, 2020 | Sale | $28.43 | 86,819 | 2,468,264 | 4,260,092 | Oct 14, 2020, 04:05 PM |
Abingworth LLP | 10% Owner | Oct 12, 2020 | Sale | $29.09 | 115,541 | 3,361,088 | 4,346,911 | Oct 14, 2020, 04:05 PM |
Chen Richard | Chief Scientific Officer | Oct 01, 2020 | Option Exercise | $0.44 | 37,452 | 16,479 | 152,750 | Oct 05, 2020, 07:00 PM |
Chen Richard | Chief Scientific Officer | Oct 01, 2020 | Sale | $22.06 | 40,000 | 882,452 | 139,278 | Oct 05, 2020, 07:00 PM |
Chen Richard | Chief Scientific Officer | Sep 17, 2020 | Sale | $22.74 | 1,120 | 25,469 | 115,298 | Sep 21, 2020, 07:05 PM |
Tachibana Aaron | Chief Financial Officer | Sep 17, 2020 | Sale | $22.74 | 2,463 | 56,009 | 178,608 | Sep 21, 2020, 07:03 PM |
Tachibana Aaron | Chief Financial Officer | Sep 02, 2020 | Sale | $22.99 | 2,899 | 66,648 | 181,071 | Sep 04, 2020, 06:41 PM |
Chen Richard | Chief Scientific Officer | Sep 02, 2020 | Sale | $22.99 | 291 | 6,690 | 116,418 | Sep 04, 2020, 06:39 PM |
Abingworth LLP | 10% Owner | Aug 18, 2020 | Sale | $19.00 | 986,842 | 18,749,998 | 4,462,452 | Aug 20, 2020, 04:00 PM |
Chen Richard | Chief Scientific Officer | Aug 14, 2020 | Sale | $20.14 | 32,000 | 644,392 | 145,275 | Aug 18, 2020, 09:47 PM |
LUDLUM KEN | Director | Aug 14, 2020 | Sale | $20.17 | 20,000 | 403,394 | 36,470 | Aug 18, 2020, 09:35 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Aug 14, 2020 | Buy | $19.00 | 1,315,789 | 24,999,991 | 1,774,240 | Aug 18, 2020, 05:01 PM |
Chen Richard | Chief Scientific Officer | Jun 22, 2020 | Sale | $12.37 | 1,085 | 13,421 | 120,143 | Jun 24, 2020, 05:48 PM |
Chen Richard | Chief Scientific Officer | Jun 05, 2020 | Sale | $14.34 | 272 | 3,900 | 121,228 | Jun 11, 2020, 07:06 PM |
Chen Richard | Chief Scientific Officer | Jun 01, 2020 | Sale | $13.19 | 289 | 3,812 | 121,211 | Jun 03, 2020, 07:21 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Jun 02, 2020 | Buy | $13.98 | 380,654 | 5,321,543 | 458,451 | Jun 03, 2020, 05:00 PM |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | Jun 01, 2020 | Buy | $12.98 | 77,797 | 1,009,805 | 77,797 | Jun 03, 2020, 05:00 PM |
Chen Richard | Chief Scientific Officer | Mar 09, 2020 | Sale | $7.84 | 1,000 | 7,840 | 59,000 | Mar 11, 2020, 05:37 PM |
Chen Richard | Chief Scientific Officer | Feb 25, 2020 | Sale | $8.77 | 101,000 | 885,770 | 59,000 | Mar 11, 2020, 05:34 PM |
Chen Richard | Chief Scientific Officer | Mar 02, 2020 | Sale | $8.76 | 1,000 | 8,760 | 59,000 | Mar 04, 2020, 06:05 PM |
Chen Richard | Chief Scientific Officer | Feb 25, 2020 | Sale | $8.77 | 101,000 | 885,770 | 59,000 | Feb 27, 2020, 09:40 PM |
LUDLUM KEN | Director | Feb 07, 2020 | Option Exercise | $3.80 | 4,167 | 15,835 | 50,000 | Feb 11, 2020, 06:44 PM |
Chen Richard | Chief Scientific Officer | Jan 07, 2020 | Option Exercise | $0.44 | 12,000 | 5,280 | 59,000 | Jan 09, 2020, 07:57 PM |
Chen Richard | Chief Scientific Officer | Dec 20, 2019 | Option Exercise | $0.44 | 12,000 | 5,280 | 47,000 | Dec 26, 2019, 06:54 PM |
West John Stephen | President and CEO | Nov 22, 2019 | Option Exercise | $8.65 | 3,000 | 25,952 | 505,412 | Nov 25, 2019, 06:40 PM |
RICCI PAUL | Director | Jun 24, 2019 | Buy | $17.00 | 40,000 | 680,000 | 20,000 | Jun 24, 2019, 08:02 PM |
LUDLUM KEN | Director | Jun 24, 2019 | Buy | $17.00 | 70,000 | 1,190,000 | 70,000 | Jun 24, 2019, 08:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Moore Stephen Michael | SVP and Chief Legal Officer | 04/30/2024 | 6,197 |
MYERS WOODROW A JR | Director | 03/01/2024 | 16,700 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP | 01/29/2024 | 721 |
Tachibana Aaron | CFO AND COO | 01/29/2024 | 981 |
Chen Richard | Chief Medical Officer and EVP | 12/15/2023 | 6,921 |
Tachibana Aaron | CFO and COO | 12/15/2023 | 9,918 |
Moore Stephen Michael | General Counsel | 12/15/2023 | 2,170 |
Moore Stephen Michael | General Counsel | 11/16/2023 | 1,791 |
Tachibana Aaron | CFO and COO | 11/16/2023 | 1,398 |
Chen Richard | Chief Medical Officer and EVP | 11/16/2023 | 978 |
Hall Christopher M | President and CEO | 11/01/2023 | 19,027 |
Tachibana Aaron | CFO and COO | 07/31/2023 | 1,496 |
Chen Richard | Chief Medical Officer and EVP | 07/31/2023 | 1,096 |
Moore Stephen Michael | General Counsel | 06/16/2023 | 3,124 |
Chen Richard | Chief Medical Officer and EVP | 06/16/2023 | 9,971 |
Tachibana Aaron | CFO and COO | 06/16/2023 | 14,291 |
Tachibana Aaron | CFO and COO | 05/17/2023 | 2,750 |
Moore Stephen Michael | General Counsel | 05/17/2023 | 3,526 |
Chen Richard | Chief Medical Officer and EVP | 05/17/2023 | 1,923 |
Moore Stephen Michael | General Counsel | 05/02/2023 | 11,684 |
Tachibana Aaron | CFO and COO | 03/17/2023 | 11,164 |
Chen Richard | Chief Medical Officer and EVP | 03/17/2023 | 3,719 |
Tachibana Aaron | Chief Financial Officer | 01/31/2023 | 1,687 |
Chen Richard | Chief Medical Officer | 01/31/2023 | 1,236 |
Tachibana Aaron | Chief Financial Officer | 12/20/2022 | 7,379 |
Chen Richard | Chief Medical Officer | 12/20/2022 | 3,360 |
Moore Stephen Michael | General Counsel | 12/15/2022 | 4,825 |
Tachibana Aaron | Chief Financial Officer | 12/15/2022 | 17,943 |
Chen Richard | Chief Medical Officer | 12/15/2022 | 17,943 |
West John Stephen | President and CEO | 12/14/2022 | 24,400 |
Tachibana Aaron | Chief Financial Officer | 12/02/2022 | 11,336 |
Chen Richard | Chief Medical Officer | 12/02/2022 | 1,144 |
Chen Richard | Chief Medical Officer | 11/16/2022 | 3,509 |
Moore Stephen Michael | General Counsel | 11/16/2022 | 5,542 |
Tachibana Aaron | Chief Financial Officer | 11/16/2022 | 3,507 |
Chen Richard | Chief Medical Officer | 09/20/2022 | 5,502 |
Tachibana Aaron | Chief Financial Officer | 09/20/2022 | 12,090 |
Chen Richard | Chief Medical Officer | 09/02/2022 | 1,399 |
Tachibana Aaron | Chief Financial Officer | 09/02/2022 | 13,879 |
Chen Richard | Chief Medical Officer | 07/28/2022 | 2,471 |
Tachibana Aaron | Chief Financial Officer | 07/28/2022 | 2,471 |
Chen Richard | Chief Medical Officer | 06/17/2022 | 5,149 |
Tachibana Aaron | Chief Financial Officer | 06/17/2022 | 11,318 |
Moore Stephen Michael | General Counsel | 06/15/2022 | 5,936 |
Chen Richard | Chief Medical Officer | 06/15/2022 | 22,090 |
Tachibana Aaron | Chief Financial Officer | 06/15/2022 | 22,090 |
Tachibana Aaron | Chief Financial Officer | 06/02/2022 | 15,031 |
Chen Richard | Chief Medical Officer | 06/02/2022 | 1,511 |
Tachibana Aaron | Chief Financial Officer | 05/16/2022 | 6,250 |
West John Stephen | President and CEO | 05/16/2022 | 11,703 |
Moore Stephen Michael | General Counsel | 05/16/2022 | 3,227 |
Chen Richard | Chief Medical Officer | 04/29/2022 | 7,416 |
Chen Richard | Chief Medical Officer | 05/16/2022 | 6,250 |
Moore Stephen Michael | General Counsel | 05/02/2022 | 31,703 |
West John Stephen | President and CEO | 04/20/2022 | 82,912 |
West John Stephen | President and CEO | 04/13/2022 | 118,551 |
West John Stephen | President and CEO | 03/17/2022 | 99,998 |
Tachibana Aaron | Chief Financial Officer | 03/17/2022 | 30,061 |
Chen Richard | Chief Medical Officer | 03/17/2022 | 14,172 |
West John Stephen | President and CEO | 03/15/2022 | 125,418 |
West John Stephen | President and CEO | 03/14/2022 | 39,019 |
West John Stephen | President and CEO | 03/15/2022 | 509,170 |
West John Stephen | President and CEO | 03/14/2022 | 172,829 |
West John Stephen | President and CEO | 03/11/2022 | 20,034 |
West John Stephen | President and CEO | 03/10/2022 | 60,530 |
West John Stephen | President and CEO | 03/11/2022 | 97,883 |
West John Stephen | President and CEO | 03/10/2022 | 308,574 |
West John Stephen | President and CEO | 03/11/2022 | 97,883 |
West John Stephen | President and CEO | 03/10/2022 | 308,574 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 03/03/2022 | 49,305 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 03/03/2022 | 2,565,738 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 03/02/2022 | 487,930 |
Chen Richard | Chief Medical Officer | 03/02/2022 | 4,795 |
Tachibana Aaron | Chief Financial Officer | 03/02/2022 | 45,922 |
Chen Richard | Chief Medical Officer | 01/28/2022 | 7,001 |
Tachibana Aaron | Chief Financial Officer | 01/28/2022 | 7,001 |
West John Stephen | President and CEO | 01/19/2022 | 710,178 |
West John Stephen | President and CEO | 01/18/2022 | 416,227 |
Tachibana Aaron | Chief Financial Officer | 12/17/2021 | 43,994 |
Chen Richard | Chief Medical Officer | 12/17/2021 | 20,006 |
West John Stephen | President and CEO | 12/17/2021 | 34,970 |
West John Stephen | President and CEO | 12/16/2021 | 1,305,337 |
Chen Richard | Chief Medical Officer | 12/02/2021 | 5,413 |
Tachibana Aaron | Chief Financial Officer | 12/02/2021 | 54,057 |
West John Stephen | President and CEO | 11/30/2021 | 1,365,000 |
West John Stephen | President and CEO | 11/17/2021 | 40,010 |
Tachibana Aaron | Chief Financial Officer | 11/17/2021 | 21,351 |
Chen Richard | Chief Medical Officer | 10/29/2021 | 11,859 |
Chen Richard | Chief Medical Officer | 11/17/2021 | 21,351 |
West John Stephen | President and CEO | 10/12/2021 | 1,933,000 |
Tachibana Aaron | Chief Financial Officer | 09/17/2021 | 66,980 |
Chen Richard | Chief Scientific Officer | 09/17/2021 | 23,120 |
West John Stephen | President and CEO | 09/14/2021 | 2,169,158 |
Tachibana Aaron | Chief Financial Officer | 09/02/2021 | 83,734 |
Chen Richard | Chief Scientific Officer | 09/02/2021 | 6,379 |
West John Stephen | President and CEO | 08/26/2021 | 34,000 |
West John Stephen | President and CEO | 08/19/2021 | 50,700 |
West John Stephen | President and CEO | 08/19/2021 | 1,936,983 |
Chen Richard | Chief Scientific Officer | 08/06/2021 | 329,646 |
Chen Richard | Chief Scientific Officer | 08/06/2021 | 94,132 |
West John Stephen | President and CEO | 07/15/2021 | 33,000 |
West John Stephen | President and CEO | 07/08/2021 | 48,400 |
West John Stephen | President and CEO | 07/08/2021 | 2,479,400 |
West John Stephen | President and CEO | 06/08/2021 | 48,400 |
West John Stephen | President and CEO | 06/08/2021 | 2,467,272 |
Chen Richard | Chief Scientific Officer | 06/02/2021 | 6,277 |
Chen Richard | Chief Scientific Officer | 03/17/2021 | 30,205 |
Tachibana Aaron | Chief Financial Officer | 03/17/2021 | 65,382 |
Tachibana Aaron | Chief Financial Officer | 03/02/2021 | 98,517 |
Chen Richard | Chief Scientific Officer | 03/02/2021 | 11,247 |
Chen Richard | Chief Scientific Officer | 02/01/2021 | 5,906 |
Chen Richard | Chief Scientific Officer | 02/01/2021 | 1,546,993 |
Chen Richard | Chief Scientific Officer | 12/17/2020 | 39,534 |
Tachibana Aaron | Chief Financial Officer | 12/17/2020 | 86,961 |
Chen Richard | Chief Scientific Officer | 12/01/2020 | 17,600 |
Chen Richard | Chief Scientific Officer | 12/01/2020 | 1,119,989 |
Chen Richard | Chief Scientific Officer | 12/02/2020 | 8,134 |
Tachibana Aaron | Chief Financial Officer | 12/02/2020 | 81,226 |
Abingworth LLP | Former 10% Owner | 10/20/2020 | 3,609,243 |
Abingworth LLP | 10% Owner | 10/19/2020 | 5,472,345 |
Abingworth LLP | 10% Owner | 10/16/2020 | 2,513,736 |
Abingworth LLP | 10% Owner | 10/15/2020 | 97,384 |
Abingworth LLP | 10% Owner | 10/14/2020 | 2,218,529 |
Abingworth LLP | 10% Owner | 10/13/2020 | 2,468,264 |
Abingworth LLP | 10% Owner | 10/12/2020 | 3,361,088 |
Chen Richard | Chief Scientific Officer | 10/01/2020 | 16,479 |
Chen Richard | Chief Scientific Officer | 10/01/2020 | 882,452 |
Chen Richard | Chief Scientific Officer | 09/17/2020 | 25,469 |
Tachibana Aaron | Chief Financial Officer | 09/17/2020 | 56,009 |
Tachibana Aaron | Chief Financial Officer | 09/02/2020 | 66,648 |
Chen Richard | Chief Scientific Officer | 09/02/2020 | 6,690 |
Abingworth LLP | 10% Owner | 08/18/2020 | 18,749,998 |
Chen Richard | Chief Scientific Officer | 08/14/2020 | 644,392 |
LUDLUM KEN | Director | 08/14/2020 | 403,394 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 08/14/2020 | 24,999,991 |
Chen Richard | Chief Scientific Officer | 06/22/2020 | 13,421 |
Chen Richard | Chief Scientific Officer | 06/05/2020 | 3,900 |
Chen Richard | Chief Scientific Officer | 06/01/2020 | 3,812 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 06/02/2020 | 5,321,543 |
Lightspeed Venture Partners Select IV, L.P. | Affiliate of 10% Owner | 06/01/2020 | 1,009,805 |
Chen Richard | Chief Scientific Officer | 03/09/2020 | 7,840 |
Chen Richard | Chief Scientific Officer | 02/25/2020 | 885,770 |
Chen Richard | Chief Scientific Officer | 03/02/2020 | 8,760 |
Chen Richard | Chief Scientific Officer | 02/25/2020 | 885,770 |
LUDLUM KEN | Director | 02/07/2020 | 15,835 |
Chen Richard | Chief Scientific Officer | 01/07/2020 | 5,280 |
Chen Richard | Chief Scientific Officer | 12/20/2019 | 5,280 |
West John Stephen | President and CEO | 11/22/2019 | 25,952 |
RICCI PAUL | Director | 06/24/2019 | 680,000 |
LUDLUM KEN | Director | 06/24/2019 | 1,190,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PERSONALIS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ARK INVESTMENT MANAGEMENT LLC | 6,065,473 | 0.06% | -9.08% | Growth |
BLACKROCK INC. | 3,280,721 | 0.00011% | -1.04% | Other |
RENAISSANCE TECHNOLOGIES LLC | 1,097,511 | 0.00257% | 30.53% | Other |
D. E. SHAW & CO., INC. | 181,295 | 0.00023% | -61.03% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 395,022 | 0.00005% | 1.36% | Other |
BRUCE & CO., INC. | 300,000 | 0.15% | No change | Value |
CHANGE IN SHARES OUTSTANDING FOR PERSONALIS INC
STOCK BUYBACKS FOR PERSONALIS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.85%
1Q
06/30/2023
4.04%
2Q
03/31/2023
6.11%
3Q
12/31/2022
7.20%
4Q
09/30/2022
8.00%
5Q
06/30/2022
8.67%
6Q
03/31/2022
10.23%
7Q
12/31/2021
10.68%
8Q
09/30/2021
11.42%
9Q
06/30/2021
12.82%
10Q
03/31/2021
17.35%
11Q
12/31/2020
27.29%
12Q
09/30/2020
39.87%
13Q
06/30/2020
56.30%
14Q
03/31/2020
58.23%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PERSONALIS INC
LOADING...